Margaret K Frens, MS, ATC Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 494 W 17th St Unit 2, Holland, MI 49423 Phone: 616-836-5243 Fax: 888-608-4834 |
Dr. Sara L Kane-smart, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 370 120th Ave, Holland, MI 49424 Phone: 616-396-5855 Fax: 616-396-5720 |
Dr. Michael William Wheaton, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 588 E Lakewood Blvd, Holland, MI 49424 Phone: 616-774-8345 |
Dr. Ann Monroe, M.D. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3299 N Wellness Dr Ste 150, Holland, MI 49424 Phone: 616-738-3884 |
Jenna Maki, AT, ATC Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 602 Michigan Ave, Holland, MI 49423 Phone: 616-392-5141 |
News Archive
The researchers recruited healthy older participants to two groups according to their history of tea drinking frequency and investigated both functional and structural networks to reveal the role of tea drinking on brain organization.
Using mouse models, scientists have investigated the active plasma metabolite of remdesivir, GS-441 524, and hydroxychloroquine as possible drug candidates in COVID-19. The research shows GS-441 524 could be an effective therapeutic drug against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while at the same time discounting hydroxychloroquine as a reliable anti-viral.
Novartis AG and Nestlé S.A. announced today that they have completed the purchase and sale of approximately 156 million shares of Alcon, Inc. for US$28.3 billion in cash.
Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world's first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), announced today that successful results of an acute in vivo study of its TMVI system were disclosed by Dr. Joseph Bavaria during the "Mitral Valve Therapies Prior to and in Human Investigation" program at the "Transcatheter Cardiovascular Therapeutics (TCT) 2009" annual scientific meeting on Friday.
› Verified 9 days ago